1. Home
  2. SCHL vs BIOA Comparison

SCHL vs BIOA Comparison

Compare SCHL & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholastic Corporation

SCHL

Scholastic Corporation

HOLD

Current Price

$43.61

Market Cap

842.4M

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$17.05

Market Cap

681.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCHL
BIOA
Founded
1920
2015
Country
United States
United States
Employees
N/A
62
Industry
Books
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.4M
681.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SCHL
BIOA
Price
$43.61
$17.05
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$40.00
$51.50
AVG Volume (30 Days)
240.7K
369.2K
Earning Date
03-19-2026
05-07-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
1.87
N/A
Revenue
$1,487,100,000.00
N/A
Revenue This Year
$1.88
$720.93
Revenue Next Year
$4.05
N/A
P/E Ratio
$23.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.26
$4.07
52 Week High
$43.79
$24.00

Technical Indicators

Market Signals
Indicator
SCHL
BIOA
Relative Strength Index (RSI) 66.20 49.70
Support Level $37.84 $15.49
Resistance Level N/A $19.01
Average True Range (ATR) 1.32 1.13
MACD 0.28 0.00
Stochastic Oscillator 98.23 65.68

Price Performance

Historical Comparison
SCHL
BIOA

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: